Brief: Editas Medicine Highlights Strategic Priorities at the J.P. Morgan Healthcare Conference
08/01/2024 17:56
Jan 8 (Reuters) - Editas Medicine Inc EDIT.O :
* EDITAS MEDICINE INC - STRONG FINANCIAL POSITION WITH
OPERATIONAL
RUNWAY INTO 2026
Source text for Eikon: ID:nGNXbjcf8X
Further company coverage: EDIT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Editas Medicine
See all newsEditas Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Editas Medicine, Inc. expected to post a loss of 27 cents a share - Earnings Preview
Editas Medicine Q2 net loss narrows and beats estimates
Brief: Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million
Editas Medicine down after $125 mln stock-and-warrants offering